These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 25690090

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Delivery of poorly soluble compounds by amorphous solid dispersions.
    Lee TW, Boersen NA, Hui HW, Chow SF, Wan KY, Chow AH.
    Curr Pharm Des; 2014; 20(3):303-24. PubMed ID: 23651395
    [Abstract] [Full Text] [Related]

  • 23. The Application of Modeling and Prediction to the Formation and Stability of Amorphous Solid Dispersions.
    DeBoyace K, Wildfong PLD.
    J Pharm Sci; 2018 Jan; 107(1):57-74. PubMed ID: 28389266
    [Abstract] [Full Text] [Related]

  • 24. An improved kinetics approach to describe the physical stability of amorphous solid dispersions.
    Yang J, Grey K, Doney J.
    Int J Pharm; 2010 Jan 15; 384(1-2):24-31. PubMed ID: 19786081
    [Abstract] [Full Text] [Related]

  • 25. Solid dispersions, part I: recent evolutions and future opportunities in manufacturing methods for dissolution rate enhancement of poorly water-soluble drugs.
    Bikiaris DN.
    Expert Opin Drug Deliv; 2011 Nov 15; 8(11):1501-19. PubMed ID: 21919807
    [Abstract] [Full Text] [Related]

  • 26. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.
    Vasconcelos T, Sarmento B, Costa P.
    Drug Discov Today; 2007 Dec 15; 12(23-24):1068-75. PubMed ID: 18061887
    [Abstract] [Full Text] [Related]

  • 27. Evolution of supersaturation of amorphous pharmaceuticals: nonlinear rate of supersaturation generation regulated by matrix diffusion.
    Sun DD, Lee PI.
    Mol Pharm; 2015 Apr 06; 12(4):1203-15. PubMed ID: 25775257
    [Abstract] [Full Text] [Related]

  • 28. Thermal Stability of Amorphous Solid Dispersions.
    Jelić D.
    Molecules; 2021 Jan 05; 26(1):. PubMed ID: 33466393
    [Abstract] [Full Text] [Related]

  • 29. Polymeric formulations for drug release prepared by hot melt extrusion: application and characterization.
    Stanković M, Frijlink HW, Hinrichs WL.
    Drug Discov Today; 2015 Jul 05; 20(7):812-23. PubMed ID: 25660507
    [Abstract] [Full Text] [Related]

  • 30. Preparation of amorphous solid dispersions by rotary evaporation and KinetiSol Dispersing: approaches to enhance solubility of a poorly water-soluble gum extract.
    Bennett RC, Brough C, Miller DA, O'Donnell KP, Keen JM, Hughey JR, Williams RO, McGinity JW.
    Drug Dev Ind Pharm; 2015 Mar 05; 41(3):382-97. PubMed ID: 24329130
    [Abstract] [Full Text] [Related]

  • 31. Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review.
    Ellenberger DJ, Miller DA, Williams RO.
    AAPS PharmSciTech; 2018 Jul 05; 19(5):1933-1956. PubMed ID: 29846889
    [Abstract] [Full Text] [Related]

  • 32. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K, Grohganz H, Laitinen R, Strachan C, Rades T.
    Eur J Pharm Biopharm; 2013 Nov 05; 85(3 Pt B):873-81. PubMed ID: 23537574
    [Abstract] [Full Text] [Related]

  • 33. Melt extrusion with poorly soluble drugs.
    Shah S, Maddineni S, Lu J, Repka MA.
    Int J Pharm; 2013 Aug 30; 453(1):233-52. PubMed ID: 23178213
    [Abstract] [Full Text] [Related]

  • 34. Designing an ADME liquid formulation with matching exposures to an amorphous dosage form.
    Xi H, Yang Z, Tatavarti A, Xu W, Fuerst J, Ormes J.
    Int J Pharm; 2019 Jan 10; 554():48-53. PubMed ID: 30236644
    [Abstract] [Full Text] [Related]

  • 35. Advances in Polymer Design for Enhancing Oral Drug Solubility and Delivery.
    Ting JM, Porter WW, Mecca JM, Bates FS, Reineke TM.
    Bioconjug Chem; 2018 Apr 18; 29(4):939-952. PubMed ID: 29319295
    [Abstract] [Full Text] [Related]

  • 36. Amorphous drug delivery systems: molecular aspects, design, and performance.
    Kaushal AM, Gupta P, Bansal AK.
    Crit Rev Ther Drug Carrier Syst; 2004 Apr 18; 21(3):133-93. PubMed ID: 15248808
    [Abstract] [Full Text] [Related]

  • 37. Current Designs of Polymer Blends in Solid Dispersions for Improving Drug Bioavailability.
    Tran PHL, Duan W, Lee BJ, Tran TTD.
    Curr Drug Metab; 2018 Apr 18; 19(13):1111-1118. PubMed ID: 29956619
    [Abstract] [Full Text] [Related]

  • 38. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
    Dukeck R, Sieger P, Karmwar P.
    Eur J Pharm Sci; 2013 Jul 16; 49(4):723-31. PubMed ID: 23684913
    [Abstract] [Full Text] [Related]

  • 39. Effect of Extent of Supersaturation on the Evolution of Kinetic Solubility Profiles.
    Han YR, Lee PI.
    Mol Pharm; 2017 Jan 03; 14(1):206-220. PubMed ID: 28043130
    [Abstract] [Full Text] [Related]

  • 40. [Progress in the research of amorphous pharmaceuticals].
    Ying J, Lü Y, Du GH.
    Yao Xue Xue Bao; 2009 May 03; 44(5):443-8. PubMed ID: 19618716
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.